EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision

Nadia M Hamdy, Al-Aliaa M Sallam, Ola Elazazy, Ahmed M Kabel, Rania M Salama, Shaimaa A Gouhar, Sherien M El-Daly, Samar F Darwish

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-11 · 398 (11) · 14785-14812

DOI: 10.1007/s00210-025-04285-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 23.05.2025. Verfasst von Nadia M Hamdy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo, 11566, Egypt. nadia_hamdy@pharma.asu.edu.eg. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Badr University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most prevalent form of primary liver cancer and one of the chief drivers of cancer-related mortality globally is hepatocellular carcinoma (HCC). Imminent evidence has indicated that non-coding RNAs (ncRNAs) play an integral part in the development and propagation of HCC. RNA stabilization, transcription regulation, chromatin and genomic architecture remodeling, enhancer-associated activity, and other varied properties set long intergenic ncRNA (lincRNA) genes apart from messenger RNA (mRNA)-encoding genes. Through a variety of processes, lincRNAs may generally be used to fine-tune the transcription of nearby genes with exceptional tissue specificity, underscoring our quickly developing knowledge of the non-coding genome. Through their binding with divergent cell targets, some HCC-related ncRNAs have been demonstrated to exhibit abnormal expression, contribute to malignant growth, evade apoptosis, and have invasive potential. Therefore, a better comprehension of lincRNA dysregulation might offer novel perspectives on the pathophysiology of HCC as well as innovative instruments for the early detection and management of HCC. In the present review, we provide an overview of the increasing relevance of lincRNAs as a major contributor to the pathophysiology of HCC, emphasizing their influence on signaling pathways implicated in the development, progression, and response to treatment of tumors. In addition, we go over the new approaches that target lincRNAs for HCC treatment as well as the possible therapeutic uses of lincRNAs as prognostic and diagnostic biomarkers for HCC. Graphical Abstract The multifaceted roles of long intergenic non-coding RNAs (lincRNAs) in hepatocellular carcinoma (HCC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRNA, Long NoncodingMicroRNAsHumansAnimalsGene Expression Regulation, NeoplasticComputer Simulation

Stichwörter der Autor:innen

In silico analysisLincRNAsLiver cancerLncRNAsNcRNAPrecision medicine

Substanzen

RNA, Long NoncodingMicroRNAs

Autor:innen und Institutionen

  • Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo, 11566, Egypt. nadia_hamdy@pharma.asu.edu.eg.
  • Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo, 11566, Egypt.
  • Biochemistry Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.
  • Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Misr International University (MIU), Cairo, Egypt.
  • Medical Biochemistry Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, 12622, Egypt.

Förderung

  • Badr University

Zitieren

APA

Hamdy, N. M., Sallam, A. M., Elazazy, O., Kabel, A. M., Salama, R. M., Gouhar, S. A., El-Daly, S. M., & Darwish, S. F. (2025). LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(11), 14785-14812. https://doi.org/10.1007/s00210-025-04285-7

Vancouver

Hamdy NM, Sallam AM, Elazazy O, Kabel AM, Salama RM, Gouhar SA, et al. LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(11):14785-14812. doi:10.1007/s00210-025-04285-7

BibTeX
@article{Hamdy2025,
  author = {Hamdy, Nadia M and Sallam, Al-Aliaa M and Elazazy, Ola and Kabel, Ahmed M and Salama, Rania M and Gouhar, Shaimaa A and El-Daly, Sherien M and Darwish, Samar F},
  title = {LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {11},
  pages = {14785--14812},
  doi = {10.1007/s00210-025-04285-7}
}
Kostenlos starten →